Assyro AI

Orange Book product · Generic (ANDA)

NAPROXEN SODIUM

NAPROXEN SODIUM

Generic (ANDA)ANDA 204872OTC LNK INTL INC
View NAPROXEN SODIUM familyOpen on FDA Orange Book

At a glance

Jan 23, 2017

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 23, 2017

    9 yr 6 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

NAPROXEN SODIUM

Strength

220MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

ANDA 204872

Product number

001

Marketing status

OTC

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of NAPROXEN SODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo